Upload Avatar (500 x 500)
Yiwei Chu
Basic Medical Sciences
Fudan University
Shanghai
Language: Chinese, English
Tumor
Immunology
Immunotherapy
Cancer
Inflammation
Transformation
Regulatory B Cells
Autoimmune
Biotherapy
Mechanisms
Areas of Focus
- Tumor Immunology and Immunobiotherapy
- Mechanisms of Inflammation and Cancer Transformation
- Regulatory B Cells and Autoimmune Diseases
Work Experience
- 2014-Present - Fudan University - Party Secretary, Institute of Biomedical Sciences
- 2013-Present - Fudan University - Head, Department of Immunology, School of Basic Medical Sciences
- 2010-Present - Fudan University - Director, Center for Biotherapy
- 2007-Present - Fudan University - Professor, Department of Immunology, School of Basic Medical Sciences
- 2003-2004 - Cancer Center of Oregon Health Science University, USA - Visiting Professor
- 1997-1998 - Cancer Center of Oregon Health Science University, USA - Visiting Scholar
- 1995-1997 - Medical College, University of Washington, USA - Visiting Scholar
Academic Background & Achievements
- 2002-2006 PhD in Immunology: Fudan University
- 1991-1994 Master's in Immunology: Shanghai Medical University
- 1983-1989 Bachelor's in Medicine: Shanghai Medical University
Publications
- Leucine tRNA Synthase-2 Expressing B Cells Contribute to Colorectal Cancer Immunoevasion, Zhiqiang Wang, Zhou Lu, Shengli lin, Jie Xia, Ziwen Zhong, Zhangjuan Xie, Yun Xing, Jingbo Qie, Mengxia Jiao, Yifan Li, Haoyu Wen, Pengyuan Zhao, Dan Zhang, Pinghong Zhou, Jiawen Qian, Feifei Luo, Luman Wang, Hongxiu Yu, Jie Liu, Jie Gu, Ronghua Liu, Yiwei Chu, 2022
- Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway, Wanwei Zheng, Huan Song, Zhongguang Luo, Hao Wu, Lin Chen, Yuedi Wang Haoshu Cui, Yufei Zhang, Bangting Wang, Wenshuai Li, Yao Liu, Jun Zhang, Yiwei Chu, Feifei Luo, Jie Liu, 2021
- MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors, Liu R, Lu Z, Gu J, Liu J, Huang E, Liu X, Wang L, Yang J, Deng Y, Qian J, Luo F, Wang Z, Zhang H, Jiang X, Zhang D, Qian J, Liu G, Zhu H, Qian Y, Liu Z, Chu Y, 2018
- MiR-15a/16-1 Suppresses AHR-dependent IL-22 Secretion in CD4+ T cells and Contributes to Immune-mediated Organ Injury, Lu Z, Liu J, Liu X, Huang E, Yang J, Qian J, Zhang D, Liu R, Chu Y, 2018
- TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells, Zhang, Feifei Luo, Yuchan Cai, Nan Liu, Luman Wang, Damo Xu and Chu Yiwei, 2011
Awards
- 2021: Shanghai Natural Science Second Prize (First Contributor)
- 2020: Chinese Medical Science and Technology Award Third Prize (First Contributor)
- 2019: Shanghai Medical Science and Technology First Prize (First Contributor)
- 2019: 31st Shanghai Excellent Invention Award (First Contributor)
- 2019: Baosteel Education Fund Excellent Teacher Award
- 2019: Fudan University Zhong Yang Style Good Teacher
- 2018: Shanghai Teaching Achievement Second Prize (First Contributor)
- 2017: Fudan University Teaching Achievement First Prize (First Contributor)
- 2016: 'Medical Immunology' Shanghai Higher Education Quality Course (Leader)
- 2013: 'Immunology' Ministry of Education First Batch of English Teaching Brand Courses (Leader)
